Al's Comment:

 This is a new approach to leptomeningeal disease - which is when the cancer spreads to the lining of the brain and /or spinal cord.  This is usually a very bad sign, with an average of about 2-3 months survival after diagnosis and no effective treatments approved yet. I wish them luck!

 


Posted on: 10/20/2021

PLUS THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR 186RNL FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES

 


Click HERE to return to brain tumor news headlines.


Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!